BE BIOPHARMA
Live / Registered — Registered (as of 25 Mar 2025)
What this means for you
Registered since 25 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90266707
- Registration number
- 7739341
- Mark type
- Stylized text
- Filed
- 20 Oct 2020
- Published for opposition
- 02 Nov 2021
- Registered
- 25 Mar 2025
- Attorney of record
- Joshua Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, immunomodulators; pharmaceutical preparations for diseases and disorders of the immune system; pharmaceutical preparations for the treatment of rare diseases
Owner
- BE BIOPHARMA, INC., Cambridge, MA, US
- BE BIOPHARMA, INC., Cambridge, MA, US
- BE BIOPHARMA, INC., CAMBRIDGE, MA, US
- Pulsar Biopharma, Inc., Boston, MA, US
Prosecution history
- 25 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 03 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 03 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 03 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Dec 2024 — USE AMENDMENT FILED
- 03 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 13 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Jun 2024 — SOU EXTENSION 5 GRANTED
- 03 Jun 2024 — SOU EXTENSION 5 FILED
- 03 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 30 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 29 Nov 2023 — SOU EXTENSION 4 GRANTED
- 29 Nov 2023 — SOU EXTENSION 4 FILED